PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology

Zheng Chen, Mincheng Yu, Jiuliang Yan, Lei Guo, Bo Zhang, Shuang Liu, Jin Lei, Wentao Zhang, Binghai Zhou, Jie Gao, Zhangfu Yang, Xiaoqiang Li, Jian Zhou, Jia Fan, Qing‐Hai Ye, Hui Li, Yongfeng Xu, Yong‐Sheng XiaoFrontiers in Immunology 2021 · DOI

TL;DR

This study identifies two key molecules, PNOC and LAIR2, as critical biomarkers for understanding the immune landscape in cholangiocarcinoma (CCA), a highly aggressive liver cancer. PNOC, expressed by B cells, is linked to better patient survival, while LAIR2, found on T cells, may indicate T cell exhaustion and worse outcomes, offering new avenues for diagnosis and treatment strategies.

What Problem Does This Paper Address?

Cholangiocarcinoma (CCA) is a devastating cancer with a poor prognosis, often diagnosed at late stages where treatment options are limited. While immunotherapy has shown promise, its effectiveness is heavily influenced by the tumor microenvironment (TME) and the types of immune cells present. However, a detailed understanding of the CCA immune TME and how specific immune cell infiltrates relate to patient outcomes has been lacking. This paper aims to characterize the immune microenvironment of CCA by identifying key genes and cell populations associated with immune infiltration and patient survival, ultimately seeking to find biomarkers that can guide immunotherapy.

Methods

The researchers employed a multi-pronged approach combining bulk sequencing and single-cell sequencing technologies.

  • Bulk Sequencing Analysis: They used gene set enrichment analysis (ssGSEA) on TCGA (The Cancer Genome Atlas) and GEO (Gene Expression Omnibus) datasets to quantify immune infiltration levels for 28 immune cell types. Differentially expressed genes between high- and low-immune infiltrated groups were identified using the edgeR package. Backward stepwise regression was then used to compress this gene list and identify key predictive genes for immune infiltration.
  • Single-Cell Sequencing Analysis: Single-cell RNA sequencing (scRNA-seq) data from CCA patients was processed using the Seurat package to cluster cells into distinct populations. This allowed for the examination of gene expression at a single-cell level, pinpointing which cell types express specific genes of interest.
  • Pathway Analysis: The scTPA web tool was used to analyze pathway changes within malignant cell populations, providing insights into their functional states and potential for progression.
  • Correlation and Survival Analysis: Various bioinformatics tools (TIMER 2.0, GEPIA, KMplotter) were used to correlate gene expression with immune infiltration scores, survival outcomes, and other immune markers.

Datasets

The study utilized publicly available datasets:

  • TCGA CHOL dataset: Used for bulk sequencing analysis of cholangiocarcinoma.
  • GEO datasets (GSE32225, GSE26566): Also used for bulk sequencing analysis to validate findings.
  • GSE138709 dataset: Provided single-cell sequencing data from intrahepatic cholangiocarcinoma patients.
  • TISIDB database: Used to obtain a meta-gene list for 28 immune cell types.

Key Insights and Ideas

  • Immune Infiltration Predicts Prognosis: Higher levels of immune cell infiltration in CCA tumors were strongly associated with better patient survival. This highlights the crucial role of the immune system in fighting CCA.
  • PNOC as a B Cell Marker and Prognostic Indicator: The study found that PNOC (prepronociceptin) is predominantly expressed by B cells within the tumor microenvironment. Crucially, higher PNOC expression was linked to better overall survival, suggesting it could serve as a positive prognostic biomarker.
  • LAIR2 as a Potential T Cell Exhaustion Marker: LAIR2 (leukocyte-associated immunoglobulin-like receptor 2) was identified as being expressed by regulatory T cells (Tregs) and a subset of CD8+ T cells (specifically CD8+/GZMB+). This expression pattern is suggestive of T cell exhaustion, a state where T cells become less effective at fighting cancer. LAIR2 expression was correlated with worse survival.
  • Heterogeneous Tumor Microenvironment: The single-cell analysis revealed distinct functional pathways and potential malignant characteristics within different CCA cell clusters, underscoring the complexity of the tumor and the need for tailored therapeutic approaches.

Key Results

  • 43 Differentially Expressed Genes: A set of 43 genes were found to be significantly upregulated in high-immune infiltrated CCA patients compared to low-infiltrated ones. These genes were largely associated with inflammatory signals and immune stimulation.
  • PNOC and LAIR2 as Key Biomarkers: Through stepwise regression, PNOC and LAIR2 emerged as significant predictors of immune infiltration status.
  • PNOC and B Cell Survival Link: High B cell infiltration scores were associated with better overall survival. PNOC expression was highly correlated with various B cell markers (CD19, CD79A, CD27, FCRL5).
  • LAIR2 and T Cell Exhaustion Markers: LAIR2 expression showed correlations with Treg markers (CD4, FOXP3, CD25) and CD8+ T cell markers (CD8A, GZMB, TIM3, PD1), supporting its role in T cell exhaustion.
  • CCA Cell Heterogeneity: Analysis of malignant CCA cells revealed distinct clusters with high self-replication potentials and others showing activated PI3K signaling, suggesting diverse malignant behaviors.

Limitations and Future Work

The authors acknowledge several limitations:

  • Protein Expression Not Examined: The study relied on mRNA expression data. Future work should include protein-level validation to confirm findings.
  • Immune Regulation Roles Unclear: The precise immune-regulating roles of PNOC (in B cells) and LAIR2 (in Tregs and CD8+ T cells) within the TME require further investigation.
  • Combination Therapy Justification: While the study suggests the potential for combining immunotherapies based on tumor heterogeneity, further experimental validation is needed.

The study proposes that PNOC and LAIR2 could serve as valuable clinical biomarkers for patient evaluation before immune therapy, aiding in predicting survival and guiding treatment decisions. Future research should focus on experimentally validating these findings and exploring their therapeutic implications.

Summary updated

Abstract

PNOC and LAIR2 were biomarkers for immune infiltration evaluation in cholangiocarcinoma. PNOC, expressed by B cells, could predict better survival of patients, while LAIR2 was a potential marker for exhaustive T cell populations, correlating with worse survival of patients.
BibTeX
@inproceedings{chen2021pnoc,
  author = {Zheng Chen and Mincheng Yu and Jiuliang Yan and Lei Guo and Bo Zhang and Shuang Liu and Jin Lei and Wentao Zhang and Binghai Zhou and Jie Gao and Zhangfu Yang and Xiaoqiang Li and Jian Zhou and Jia Fan and Qing‐Hai Ye and Hui Li and Yongfeng Xu and Yong‐Sheng Xiao},
  title = {{PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology}},
  booktitle = {Frontiers in Immunology},
  year = {2021},
  doi = {10.3389/fimmu.2021.647209},
}
Figure